S U M MARY Tryptophan, 5-hydroxyindoleacetic acid and indoleacetic acid were measured in cerebrospinal fluid taken during pneumoencephalography from patients, some of whom took a 3 g or 6 g tryptophan load at various times before. Measurements were made on both lumbar and cisternal cerebrospinal fluid and the results showed similarities between indoleamine metabolism in human brain and spinal cord. Our data suggested that (1) the blood-brain barrier active transport system for tryptophan is not far from saturation with tryptophan and the rate-limiting enzyme in 5-hydroxytryptamine (5HT) synthesis, tryptophan hydroxylase, is about half saturated. Therefore, both 3 g and 6 g tryptophan loads produced the same maximum rise in 5HT synthesis of just under 100%, (2) tryptamine differs from 5HT in two respects. It is more sensitive to changes in tryptophan availability than 5HT and the 6 g load increased brain tryptamine metabolism more than the 3 g load; also some of the tryptamine in brain is derived from peripheral sources and diffuses from blood to brain, (3) although the brain tryptamine content is much lower than that of 5HT, its rate of metabolism as indicated by CSF metabolite levels is not. In controls the rate of tryptamine metabolism is 15% of the rate of 5HT metabolism and this can increase to 40% after a 6 g tryptophan load.
The concentrations of tryptophan and 5-hydroxyindoleacetic acid (5HIAA) in human ventricular,1 2 cisternal and lumbar3 cerebrospinal fluid (CSF) are positively correlated. As CSF tryptophan reflects the CNS content of this amino acid,4 and CSF 5HIAA reflects CNS 5-hydroxytryptamine (5HT) turnover,5 6 these data indicate that tryptophan concentration is one of the factors that controls 5HT turnover in most areas of the human CNS. Tryptophan availability also seems to be one of the factors controlling human CNS tryptamine metabolism, as the concentrations in CSF of tryptophan and of the tryptamine metabolite indoleacetic acid (IAA) also are correlated.3 When humans are given a tryptophan load CSF 5HIAA rises7 and the concentration of tryptophan and 5HIAA in CSF are related. 8 The data for rats indicate that, if the size of the tryptophan load increases, tryptophan hydroxylase becomes saturated and CSF 5HIAA does not rise further. However, tryptamine metabolism appeared to be more sensitive to tryptophan administration since CSF IAA increased linearly with the size of a tryptophan load.9 The present study was designed to test whether the control of indoleamine metabolism in human CNS is similar to that in the rat, by measuring CSF tryptophan, 5HIAA and IAA in humans who received 3 or 6 g of tryptophan.
Methods
The study, performed on patients undergoing diagnostic pneumoencephalography (PEG) at the Montreal Neurological Hospital, was approved by the ethics committees of the Montreal Neurological Hospital and the Department of Psychiatry, McGill University. The purpose of the study was explained to 40 patients and they were asked if they would be willing to take tablets which contained tryptophan or placebo, before their PEG. The 38 patients who agreed to participate in the study signed consent forms. Of these 38 patients, 16 received 3 g L-tryptophan (six tablets of 500 mg), 16 received 6 g (12 tablets) and six received placebo (six tablets) at 8+: 1 or 12±+:1 hours before the PEG was started. The procedure was done on the fasting patients, without premedication, between 9.00 am and 12 noon. The first 2 ml of CSF was used for routine diagnostic purposes and the next 2 to 6 ml were collected for analysis of indoles. This sample was derived from the lumbar sac, which in humans has a volume of about 15 ml't and will be referred to in this study as lumbar CSF. Oxygen was then injected until the lateral ventricles contained oxygen. Some CSF from this compartment was thus displaced down into the basal cisterns, and when most of the oxygen had been injected (average 60 ml) a second sample of CSF (6 to 8 ml) was collected through the lumbar needle. This last sample consisted mainly of fluid that was originally in the basal cisterns and was displaced into the lumbar sac. It is referred to in this study as (fig 4) . Each figure gives data for control patients and patients who received a 3 g or 6 g tryptophan load eight hours or 12 hours before CSF was taken.
The rise of plasma tryptophan in patients receiving tryptophan loads was quite variable (fig 1) . We have also found this in depressed patients on chronic tryptophan treatment. 13 The variability is not due to the difference in doses that the patients received on a mg/kg basis as there was no relationship between plasma tryptophan and weight of the patients. Presumably there is variability between patients in the rate at which tryptophan is catabolised in the liver by tryptophan pyrrolase. Figure 1 shows that both sizes of tryptophan load increased plasma tryptophan, the increase being larger for the 6 g than for the 3 g load. For CSF tryptophan (fig 2) there was no difference between the values for the large and small load at eight hours but there was at twelve hours, when the tryptophan content of body fluids was declining. The rise of CSF 5HIAA (fig 3) , which increased slightly less than two-fold in both lumbar and cisternal samples, was relatively modest. There was no difference between the effect of the 3 g and 6 g loads but there was a tendency for the 6 g load to give higher values at 12 hours when the rise of CSF 5HIAA produced by the 3 g load was declining. At both eight and twelve hours the rise in CSF IAA was greater with 6 g tryptophan than with 3 g (fig 4) . Tryptophan loading produced similar results in cisternal and lumbar samples.
Discussion
Because the tryptophan loads were given at random, the groups were not well matched for sex and for treatment with anticonvulsants (table), two factors which are known to influence indoleamine metabolism. The differences caused by these factors are small compared with the changes produced by tryptophan administration and the uneven distribution between the groups does not affect any of the conclusions in this study. Thus, anticonvulsants lower 5HIAA but only in lumbar CSF.3 However, the pattern of results in this study is similar in CSF from lumbar and cisternal compartments. Tryptophan, 5HIAA and IAA tend to be higher in CSF from females than males. In the eight hours' samples there are more females in the 6 g group than in the 3 g group. This would tend to make the values higher for the 6 g group and yet there was no difference for tryptophan and 5HIAA between the two groups at eight hours (figs 2 and 3). At twelve hours there are more women in the 3 g group but this did not prevent elevated levels of tryptophan and IAA in the 6 g group compared with the 3 g at twelve hours ( figs 2 and 4) . Thus, the interpretation of the results is not altered by the mismatching of the groups.
One surprising aspect of our results is that the maximum (8 hour) CSF tryptophan values were not higher after 6 g tryptophan than after 3 g, even though the larger load gave higher plasma tryptophan concentrations (figs 1 and 2 ). This may reflect partly the variability of the results but it may Effect of tryptophan administration on tryptophan, SHIA A and IA A in CSF also provide information on blood-brain barrier transport of tryptophan in humans. We have studied tryptophan uptake across the blood-brain barrier in the rat and found saturable and nonsaturable (presumably diffusion) components.'4 At physiological tryptophan concentrations the saturable system was about half saturated and the diffusion component was relatively small. Thus, increases in tryptophan concentration produced relatively modest increases in the rate of tryptophan uptake. If the situation in humans is similar, the increase in the rate of transport of tryptophan from blood to brain, when the size of load is increased from 3 g to 6 g, might be small. This might explain why there is no rise in CSF tryptophan in these circumstances.
The rise of CSF tryptophan at eight hours was six to eight-fold (fig 2) , while that of 5HIAA was about two-fold (fig 3) . The rise of CSF 5HIAA seen by Eccleston et a17 eight hours after patients received a tryptophan load of 50 mg/kg was similar. These data indicate that tryptophan hydroxylase in human CNS is about half saturated. In this respect humans are like rats whose brain tryptophan concentration is close to the Km for tryptophan hydroxylase."15 1 Thus, even if much larger tryptophan loads had been given the rise of CSF 5HIAA is unlikely to have been greater.
The data in fig 4 shows that CNS tryptamine metabolism changes in response to tryptophan availability. Thus, while the smaller load increased IAA 2-2-fold in cisternal CSF at eight hours, 6g tryptophan increased it 4-4-fold. In a study on rats we also found that tryptamine metabolism was more responsive than 5HT metabolism to changes in tryptophan availability.9 Our present data on humans suggest that, as in the rat, the degree of saturation of aromatic amino acid decarboxylase with tryptophan is less than that of tryptophan hydroxylase.
At eight hours after the load, CSF IAA was higher in the patients who received 6 g tryptophan than in those who received 3 g, even though there was no difference in the CSF tryptophan concentrations at this time. There are two factors that could contribute to this result. Firstly, the larger tryptophan load might have given higher CNS tryptophan levels at earlier times. Obviously it will take some time for the tryptophan to be metabolised to tryptamine and thence to IAA and for the IAA to diffuse from tissue to CSF. Secondly, our studies in the rat have shown that some of the tryptamine in CNS is derived from peripheral sources. ' 
Conclusions
In human CNS, indoleamine metabolism is controlled in part by tryptophan availability. This is true both in physiological circumstance3 and after a tryptophan load. Presumably this would be true for dietary as well as pharmacological loads of tryptophan. Tryptamine metabolism is more sensitive than 5HT metabolism to changes in tryptophan levels and thus a tryptophan load can increase tryptamine synthesis more than 5HT synthesis. In control subjects lumbar CSF IAA is 15% of lumbar CSF 5HIAA but eight hours after a 6g tryptophan load the value has risen to 40% (figs 3 and 4). Our data on the rat indicate that the relative amounts of the metabolites in CSF reflect the relative rates of metabolism of the amines.9 Thus, even if the tryptophan content of human brain is very small compared with that of 5HT its rate of metabolism can be of the same order of magnitude. The functional significance of tryptamine in human CNS is unknown and merits further investigation. 
